Cargando…
Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
Second-line treatments of autoimmune cytopenias (AC) are not well-defined in children. Mycophenolate mofetil (MMF) is an immunosuppressant agent that has been demonstrated to be safe and effective in this setting. A retrospective observational study was conducted in 18 children with prolonged AC who...
Autores principales: | Berrueco, Rubén, González-Forster, Elisa, Deya-Martinez, Angela, Solsona, María, García-García, Ana, Calzada-Hernández, Joan, Yiyi, Luo, Vlagea, Alexandru, Ruiz-Llobet, Anna, Alsina, Laia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616248/ https://www.ncbi.nlm.nih.gov/pubmed/37915985 http://dx.doi.org/10.3389/fped.2023.1174671 |
Ejemplares similares
-
Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021) -
Acute and long-term immune responses to SARS-CoV-2 infection in unvaccinated children and young adults with inborn errors of immunity
por: García-García, Ana, et al.
Publicado: (2023) -
Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity
por: Cornelissen, Helena M., et al.
Publicado: (2022) -
COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era
por: Deyà-Martínez, A., et al.
Publicado: (2021) -
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets
por: Cortesi, Manuela, et al.
Publicado: (2022)